Cencora Operating Income 2010-2025 | COR
Cencora annual/quarterly operating income history and growth rate from 2010 to 2025. Operating income can be defined as income after operating expenses have been deducted and before interest payments and taxes have been deducted.
- Cencora operating income for the quarter ending March 31, 2025 was $1.036B, a 87.29% increase year-over-year.
- Cencora operating income for the twelve months ending March 31, 2025 was $2.542B, a 0.73% increase year-over-year.
- Cencora annual operating income for 2024 was $2.175B, a 7.07% decline from 2023.
- Cencora annual operating income for 2023 was $2.341B, a 1.08% decline from 2022.
- Cencora annual operating income for 2022 was $2.366B, a 0.52% increase from 2021.
| Cencora Annual Operating Income (Millions of US $) |
|
|---|---|
| 2024 | $2,175 |
| 2023 | $2,341 |
| 2022 | $2,366 |
| 2021 | $2,354 |
| 2020 | $-5,135 |
| 2019 | $1,112 |
| 2018 | $1,444 |
| 2017 | $1,060 |
| 2016 | $1,526 |
| 2015 | $422 |
| 2014 | $782 |
| 2013 | $898 |
| 2012 | $1,304 |
| 2011 | $1,190 |
| 2010 | $1,092 |
| 2009 | $884 |
| Cencora Quarterly Operating Income (Millions of US $) |
|
|---|---|
| 2025-03-31 | $1,036 |
| 2024-12-31 | $706 |
| 2024-09-30 | $127 |
| 2024-06-30 | $672 |
| 2024-03-31 | $553 |
| 2023-12-31 | $823 |
| 2023-09-30 | $477 |
| 2023-06-30 | $670 |
| 2023-03-31 | $561 |
| 2022-12-31 | $633 |
| 2022-09-30 | $455 |
| 2022-06-30 | $487 |
| 2022-03-31 | $780 |
| 2021-12-31 | $644 |
| 2021-09-30 | $562 |
| 2021-06-30 | $621 |
| 2021-03-31 | $624 |
| 2020-12-31 | $547 |
| 2020-09-30 | $-6,113 |
| 2020-06-30 | $405 |
| 2020-03-31 | $310 |
| 2019-12-31 | $263 |
| 2019-09-30 | $180 |
| 2019-06-30 | $407 |
| 2019-03-31 | $48 |
| 2018-12-31 | $478 |
| 2018-09-30 | $154 |
| 2018-06-30 | $389 |
| 2018-03-31 | $481 |
| 2017-12-31 | $419 |
| 2017-09-30 | $-135 |
| 2017-06-30 | $170 |
| 2017-03-31 | $625 |
| 2016-12-31 | $400 |
| 2016-09-30 | $225 |
| 2016-06-30 | $529 |
| 2016-03-31 | $950 |
| 2015-12-31 | $-178 |
| 2015-09-30 | $542 |
| 2015-06-30 | $333 |
| 2015-03-31 | $-364 |
| 2014-12-31 | $-88 |
| 2014-09-30 | $210 |
| 2014-06-30 | $111 |
| 2014-03-31 | $301 |
| 2013-12-31 | $160 |
| 2013-09-30 | $114 |
| 2013-06-30 | $135 |
| 2013-03-31 | $350 |
| 2012-12-31 | $299 |
| 2012-09-30 | $321 |
| 2012-06-30 | $324 |
| 2012-03-31 | $377 |
| 2011-12-31 | $281 |
| 2011-09-30 | $230 |
| 2011-06-30 | $317 |
| 2011-03-31 | $365 |
| 2010-12-31 | $277 |
| 2010-09-30 | $236 |
| 2010-06-30 | $282 |
| 2010-03-31 | $311 |
| 2009-12-31 | $262 |
| 2009-09-30 | $225 |
| 2009-06-30 | $213 |
| 2009-03-31 | $248 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $57.219B | $293.959B |
| CENCORA INC is a healthcare solutions provider. CENCORA INC., formerly known as AmerisourceBergen, is based in CONSHOHOCKEN, Pa. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $146.605B | 27.50 |
| CVS Health (CVS) | United States | $81.948B | 10.19 |
| Elevance Health (ELV) | United States | $76.969B | 9.93 |
| DiDi Global (DIDIY) | China | $24.191B | 25.70 |
| Natera (NTRA) | United States | $21.906B | 0.00 |
| Labcorp Holdings (LH) | United States | $20.893B | 16.95 |
| BioMerieux (BMXMF) | France | $16.861B | 0.00 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $13.687B | 0.00 |
| CochLear (CHEOY) | Australia | $12.827B | 0.00 |
| Solventum (SOLV) | United States | $12.768B | 13.52 |
| ICON (ICLR) | Ireland | $12.156B | 11.30 |
| Revvity (RVTY) | United States | $11.964B | 20.59 |
| Viatris (VTRS) | United States | $10.704B | 3.68 |
| Medpace Holdings (MEDP) | United States | $9.298B | 24.69 |
| Avantor (AVTR) | United States | $9.254B | 13.45 |
| Sonic Healthcare (SKHHY) | Australia | $8.886B | 0.00 |
| HealthEquity (HQY) | United States | $8.174B | 35.80 |
| Charles River Laboratories (CRL) | United States | $7.829B | 15.34 |
| Caris Life Sciences,�Inc (CAI) | United States | $6.744B | 0.00 |
| Amplifon S.p.A (AMFPF) | Italy | $5.378B | 29.44 |
| Bausch + Lomb (BLCO) | Canada | $4.911B | 28.92 |
| BrightSpring Health Services (BTSG) | United States | $3.571B | 32.76 |
| Sotera Health (SHC) | United States | $3.349B | 19.03 |
| Surgery Partners (SGRY) | United States | $2.825B | 36.73 |
| Alignment Healthcare (ALHC) | United States | $2.645B | 0.00 |
| Organon (OGN) | United States | $2.584B | 2.75 |
| Concentras Parent (CON) | United States | $2.551B | 14.74 |
| GeneDx Holdings (WGS) | United States | $2.356B | 90.72 |
| Ardent Health (ARDT) | United States | $2.027B | 8.64 |
| Progyny (PGNY) | United States | $1.990B | 43.79 |
| PACS (PACS) | United States | $1.932B | 0.00 |
| Premier (PINC) | United States | $1.736B | 13.18 |
| GoodRx Holdings (GDRX) | United States | $1.695B | 33.89 |
| Teladoc Health (TDOC) | United States | $1.460B | 0.00 |
| Establishment Labs Holdings (ESTA) | $1.298B | 0.00 | |
| Pediatrix Medical (MD) | United States | $1.127B | 8.58 |
| CareDx (CDNA) | United States | $1.121B | 17.50 |
| Ryman Healthcare (RYHTY) | New Zealand | $0.970B | 0.00 |
| Agilon Health (AGL) | United States | $0.923B | 0.00 |
| QDM (QDMI) | Hong Kong, SAR China | $0.848B | 291.00 |
| AMN Healthcare Services Inc (AMN) | United States | $0.810B | 7.58 |
| Nutex Health (NUTX) | United States | $0.637B | 9.64 |
| Embecta (EMBC) | United States | $0.612B | 4.12 |
| InnovAge Holding (INNV) | United States | $0.559B | 0.00 |
| SBC Medicals (SBC) | United States | $0.523B | 0.00 |
| LifeMD (LFMD) | United States | $0.512B | 0.00 |
| Sonida Senior Living (SNDA) | United States | $0.482B | 0.00 |
| Auna S.A (AUNA) | Luxembourg | $0.471B | 10.60 |
| Omada Health (OMDA) | $0.455B | 0.00 | |
| So-Young (SY) | China | $0.390B | 0.00 |
| Enhabit (EHAB) | United States | $0.357B | 29.38 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.344B | 0.00 |
| Performant Healthcare (PHLT) | United States | $0.321B | 0.00 |
| Oncology Institute (TOI) | United States | $0.279B | 0.00 |
| Beauty Health (SKIN) | United States | $0.241B | 0.00 |
| DocGo (DCGO) | United States | $0.152B | 24.83 |
| Pheton Holdings (PTHL) | China | $0.138B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.107B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.079B | 0.00 |
| KindlyMD (NAKA) | United States | $0.074B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.061B | 0.00 |
| NeueHealth (NEUE) | United States | $0.061B | 0.00 |
| ModivCare (MODV) | United States | $0.046B | 0.00 |
| Biodesix (BDSX) | United States | $0.045B | 0.00 |
| Basel Medical Group (BMGL) | Singapore | $0.042B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.035B | 0.00 |
| OSR Holdings (OSRH) | United States | $0.023B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.012B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.009B | 0.00 | |
| Co-Diagnostics (CODX) | United States | $0.008B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.007B | 0.00 |
| XWELL (XWEL) | United States | $0.005B | 0.00 |
| Aclarion (ACON) | United States | $0.004B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.003B | 0.00 |
| ISpecimen (ISPC) | United States | $0.003B | 0.00 |
| INVO Fertility (IVF) | United States | $0.002B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |